2 Comments
May 17, 2023Liked by Jesse Johnson

Spot on with this excerpt - ‘In “traditional” drug development, this is pretty standard. But for most biotech startups, this is what makes them unique. Their secret sauce, if you will. So of course off-the-shelf software isn’t going to reflect this part of their workflow model’

This is where services and implementations come in. Most LIMs companies will provide an OOTB solution that gets you 60-80% there.

Expand full comment